Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Recruiting · NCT07549698 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, autoimmune hemolytic anemia, warm type, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 1 / Phase 2 | 2026-09-22 | NCT07549698 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CRISPR Therapeutics AG | 5 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Gregorio Marañón General University Hospital | Madrid | Spain | 2 |
| Hospital Universitario La Paz | Madrid | Spain | 75 |
| Hospital Universitario Reina Sofia | Córdoba | Spain | 67 |
| Hospital Universitario Virgen del Rocio | Seville | Spain | 42 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |
| Medizinische Hochschule Hannover | Hannover | Germany | 1 |
| Medizinische Hochschule Hannover (MHH) | Hanover | Germany | 11 |
| UCT University Medical Center Mainz | Mainz | Germany | 2 |
| Universitaetsklinikum Koeln | Cologne | Germany | 5 |
| University of Nebraska Medical Center | Omaha | United States | 397 |